NRNP 6665 Week 11 Final Exam
Questions and Answers Latest () (Verified Answers)
Psychiatric-Mental Health Nurse Practitioner (PMHNP-BC)
Advanced Practice Psychiatric Nursing Education
Total Questions 165 (Verified Answers)
Sections 9 Comprehensive Domains
Question Format Multiple Choice (A-D)
Cognitive Levels 25% Recall | 55% Application | 20% Analysis
Content Style 75% Scenario-Based | 25% Direct Recall
Edition Latest (Verified)
Alignment Walden University NRNP 6665 Week 11 Capstone
Standards DSM-5-TR | FDA | APA | ANCC PMHNP-BC
This examination is designed to support preparation for the NRNP 6665 Week 11 Final Exam and the ANCC
Psychiatric-Mental Health Nurse Practitioner Board Certification (PMHNP-BC). Content reflects current
(2026-2027) DSM-5-TR diagnostic criteria, FDA approvals, black box warnings, and evidence-based prescribing
guidelines. Each question includes a verified correct answer and detailed PMHNP-level rationale addressing
neurobiological mechanisms, pharmacological principles, clinical guidelines, and safety considerations. This
document is an educational study aid and does not substitute for clinical judgment or supervision in PMHNP
practice.
,NRNP 6665 Week 11 Final Exam - Questions and Answers (Verified) Edition
Examination Overview
This comprehensive examination consists of 165 verified multiple-choice questions organized into nine content
domains aligned with the NRNP 6665 PMHNP curriculum and Week 11 capstone competencies. The
examination integrates foundational PMHNP knowledge (role, scope, ethics, legal, therapeutic relationships),
psychiatric assessment and diagnostic reasoning (Mental Status Examination, DSM-5-TR criteria, differential
diagnosis, screening instruments), neurobiology and psychopharmacology (neurotransmitters, receptors,
pharmacokinetics, pharmacogenomics), and clinical management across depressive, bipolar, anxiety, OCD,
trauma-related, schizophrenia spectrum, and substance use disorders. Special attention is given to special
populations (pediatric, geriatric, perinatal, cultural), psychotherapy modalities, crisis intervention, suicide risk
assessment, documentation standards, and Week 11 capstone integration scenarios requiring advanced
clinical judgment.
Section Domain Question Range Count
Section 1 Section 1 Q1-Q15 15
Section 2 Section 2 Q16-Q32 17
Section 3 Section 3 Q33-Q48 16
Section 4 Section 4 Q49-Q72 24
Section 5 Section 5 Q73-Q92 20
Section 6 Section 6 Q93-Q114 22
Section 7 Section 7 Q115-Q132 18
Section 8 Section 8 Q133-Q150 18
Section 9 Section 9 Q151-Q165 15
Cognitive Level Distribution: 25% Recall (basic facts, diagnostic criteria, drug classifications) | 55%
Application (medication selection scenarios, monitoring parameters, drug interactions, special population
prescribing) | 20% Analysis (differential diagnosis, commonly confused condition pairs, Week 11 capstone
integration scenarios).
Page 2
,NRNP 6665 Week 11 Final Exam - Questions and Answers (Verified) Edition
Section 1: Foundations of PMHNP Practice
Role, Scope, Ethics, Legal, & Therapeutic Relationships
Q1: A PMHNP candidate is preparing for national certification. Which organization administers the
Psychiatric-Mental Health Nurse Practitioner Certification (PMHNP-BC) examination and is recognized
as the primary credentialing body for advanced practice psychiatric nurses in the United States?
A. American Nurses Credentialing Center (ANCC) [CORRECT]
B. American Association of Nurse Practitioners (AANP)
C. American Psychiatric Nurses Association (APNA)
D. National Council of State Boards of Nursing (NCSBN)
Correct Answer: A
Rationale: The American Nurses Credentialing Center (ANCC) administers the Psychiatric-Mental Health Nurse
Practitioner Board Certification (PMHNP-BC) examination, which is the nationally recognized credential for entry
into advanced practice psychiatric nursing. The AANP primarily certifies family and adult-gerontology primary
care NPs and does not offer a PMHNP-specific examination. APNA is a professional organization that provides
education and advocacy but does not administer board certification. The NCSBN develops the NCLEX-RN for
entry-level nursing licensure but is not the certifying body for advanced practice psychiatric nurses.
Q2: A newly licensed PMHNP is accepting a position in a state with reduced practice authority. Which
statement most accurately describes the implication for this clinician's prescriptive authority for
psychotropic medications?
A. The PMHNP may prescribe independently without any collaborative agreement requirements.
B. The PMHNP must have a collaborative agreement with a physician for at least one element of
practice, including prescriptive authority. [CORRECT]
C. The PMHNP may only prescribe non-controlled substances and must refer all controlled substance
prescribing to a physician.
D. The PMHNP has full independent prescriptive authority for all controlled substances including Schedule II
opioids.
Correct Answer: B
Rationale: In reduced practice states, the PMHNP must enter into a regulated collaborative agreement with a
physician for at least one element of practice, which typically includes prescriptive authority for controlled
substances. Full practice authority (option A) is reserved for full-practice states. Option C is incorrect because
reduced practice does not categorically prohibit controlled substance prescribing; rather, it requires collaboration.
Option D reflects full practice authority, which exceeds the reduced practice designation. The PMHNP must verify
specific state regulatory requirements through the state Board of Nursing.
Page 3
, NRNP 6665 Week 11 Final Exam - Questions and Answers (Verified) Edition
Q3: A 32-year-old patient with treatment-resistant schizophrenia has been stabilized on clozapine 400
mg/day. The patient discloses to the PMHNP that he has been having homicidal ideation toward a
specific coworker whom he believes is poisoning him. Which action represents the PMHNP's legal
obligation under the Tarasoff duty?
A. Maintain strict confidentiality because the patient has only expressed ideation without a specific plan.
B. Notify law enforcement and the identifiable potential victim directly, regardless of patient
consent. [CORRECT]
C. Increase the clozapine dose and reevaluate in one week before any disclosure.
D. Document the ideation and continue therapy without breach of confidentiality.
Correct Answer: B
Rationale: The Tarasoff duty (duty to warn/protect) requires the PMHNP to breach confidentiality when there is a
serious, credible threat of harm toward an identifiable victim. The presence of delusional content (poisoning
belief), homicidal ideation toward a specific coworker, and the patient's diagnosis of a psychotic disorder together
constitute a serious and foreseeable risk. The clinician must take reasonable steps to protect the victim, including
notifying law enforcement and warning the identified individual. Option A and D represent a breach of the duty to
warn. Option C delays protective action and is clinically inappropriate given the seriousness of the threat.
Documentation of the rationale and actions taken is also required.
Q4: A PMHNP is initiating care with a 45-year-old patient who is being evaluated for major depressive
disorder. The patient states, "I don't want to talk to anyone about my medications — just tell me what
to take." Which response best demonstrates the principle of informed consent in PMHNP practice?
A. "I'll decide the best medication for you based on my expertise and start it today."
B. "You have the right to understand the benefits, risks, alternatives, and consequences of refusing
treatment before we proceed." [CORRECT]
C. "If you refuse treatment, I'll need to document that you are non-adherent and discontinue care."
D. "You don't need to know all the details; just trust that I am the expert here."
Correct Answer: B
Rationale: Informed consent requires that the patient receive clear information about the diagnosis, proposed
treatment, expected benefits, potential risks and adverse effects, reasonable alternatives, and the consequences
of refusing treatment — all in language the patient can understand. The PMHNP must also assess the patient's
decisional capacity. Option A reflects paternalism and violates autonomy. Option C is coercive and constitutes
abandonment risk. Option D reflects a violation of professional standards and informed consent doctrine. Even
when patients defer decisions to the clinician, the consent process must still be completed and documented.
Page 4
Questions and Answers Latest () (Verified Answers)
Psychiatric-Mental Health Nurse Practitioner (PMHNP-BC)
Advanced Practice Psychiatric Nursing Education
Total Questions 165 (Verified Answers)
Sections 9 Comprehensive Domains
Question Format Multiple Choice (A-D)
Cognitive Levels 25% Recall | 55% Application | 20% Analysis
Content Style 75% Scenario-Based | 25% Direct Recall
Edition Latest (Verified)
Alignment Walden University NRNP 6665 Week 11 Capstone
Standards DSM-5-TR | FDA | APA | ANCC PMHNP-BC
This examination is designed to support preparation for the NRNP 6665 Week 11 Final Exam and the ANCC
Psychiatric-Mental Health Nurse Practitioner Board Certification (PMHNP-BC). Content reflects current
(2026-2027) DSM-5-TR diagnostic criteria, FDA approvals, black box warnings, and evidence-based prescribing
guidelines. Each question includes a verified correct answer and detailed PMHNP-level rationale addressing
neurobiological mechanisms, pharmacological principles, clinical guidelines, and safety considerations. This
document is an educational study aid and does not substitute for clinical judgment or supervision in PMHNP
practice.
,NRNP 6665 Week 11 Final Exam - Questions and Answers (Verified) Edition
Examination Overview
This comprehensive examination consists of 165 verified multiple-choice questions organized into nine content
domains aligned with the NRNP 6665 PMHNP curriculum and Week 11 capstone competencies. The
examination integrates foundational PMHNP knowledge (role, scope, ethics, legal, therapeutic relationships),
psychiatric assessment and diagnostic reasoning (Mental Status Examination, DSM-5-TR criteria, differential
diagnosis, screening instruments), neurobiology and psychopharmacology (neurotransmitters, receptors,
pharmacokinetics, pharmacogenomics), and clinical management across depressive, bipolar, anxiety, OCD,
trauma-related, schizophrenia spectrum, and substance use disorders. Special attention is given to special
populations (pediatric, geriatric, perinatal, cultural), psychotherapy modalities, crisis intervention, suicide risk
assessment, documentation standards, and Week 11 capstone integration scenarios requiring advanced
clinical judgment.
Section Domain Question Range Count
Section 1 Section 1 Q1-Q15 15
Section 2 Section 2 Q16-Q32 17
Section 3 Section 3 Q33-Q48 16
Section 4 Section 4 Q49-Q72 24
Section 5 Section 5 Q73-Q92 20
Section 6 Section 6 Q93-Q114 22
Section 7 Section 7 Q115-Q132 18
Section 8 Section 8 Q133-Q150 18
Section 9 Section 9 Q151-Q165 15
Cognitive Level Distribution: 25% Recall (basic facts, diagnostic criteria, drug classifications) | 55%
Application (medication selection scenarios, monitoring parameters, drug interactions, special population
prescribing) | 20% Analysis (differential diagnosis, commonly confused condition pairs, Week 11 capstone
integration scenarios).
Page 2
,NRNP 6665 Week 11 Final Exam - Questions and Answers (Verified) Edition
Section 1: Foundations of PMHNP Practice
Role, Scope, Ethics, Legal, & Therapeutic Relationships
Q1: A PMHNP candidate is preparing for national certification. Which organization administers the
Psychiatric-Mental Health Nurse Practitioner Certification (PMHNP-BC) examination and is recognized
as the primary credentialing body for advanced practice psychiatric nurses in the United States?
A. American Nurses Credentialing Center (ANCC) [CORRECT]
B. American Association of Nurse Practitioners (AANP)
C. American Psychiatric Nurses Association (APNA)
D. National Council of State Boards of Nursing (NCSBN)
Correct Answer: A
Rationale: The American Nurses Credentialing Center (ANCC) administers the Psychiatric-Mental Health Nurse
Practitioner Board Certification (PMHNP-BC) examination, which is the nationally recognized credential for entry
into advanced practice psychiatric nursing. The AANP primarily certifies family and adult-gerontology primary
care NPs and does not offer a PMHNP-specific examination. APNA is a professional organization that provides
education and advocacy but does not administer board certification. The NCSBN develops the NCLEX-RN for
entry-level nursing licensure but is not the certifying body for advanced practice psychiatric nurses.
Q2: A newly licensed PMHNP is accepting a position in a state with reduced practice authority. Which
statement most accurately describes the implication for this clinician's prescriptive authority for
psychotropic medications?
A. The PMHNP may prescribe independently without any collaborative agreement requirements.
B. The PMHNP must have a collaborative agreement with a physician for at least one element of
practice, including prescriptive authority. [CORRECT]
C. The PMHNP may only prescribe non-controlled substances and must refer all controlled substance
prescribing to a physician.
D. The PMHNP has full independent prescriptive authority for all controlled substances including Schedule II
opioids.
Correct Answer: B
Rationale: In reduced practice states, the PMHNP must enter into a regulated collaborative agreement with a
physician for at least one element of practice, which typically includes prescriptive authority for controlled
substances. Full practice authority (option A) is reserved for full-practice states. Option C is incorrect because
reduced practice does not categorically prohibit controlled substance prescribing; rather, it requires collaboration.
Option D reflects full practice authority, which exceeds the reduced practice designation. The PMHNP must verify
specific state regulatory requirements through the state Board of Nursing.
Page 3
, NRNP 6665 Week 11 Final Exam - Questions and Answers (Verified) Edition
Q3: A 32-year-old patient with treatment-resistant schizophrenia has been stabilized on clozapine 400
mg/day. The patient discloses to the PMHNP that he has been having homicidal ideation toward a
specific coworker whom he believes is poisoning him. Which action represents the PMHNP's legal
obligation under the Tarasoff duty?
A. Maintain strict confidentiality because the patient has only expressed ideation without a specific plan.
B. Notify law enforcement and the identifiable potential victim directly, regardless of patient
consent. [CORRECT]
C. Increase the clozapine dose and reevaluate in one week before any disclosure.
D. Document the ideation and continue therapy without breach of confidentiality.
Correct Answer: B
Rationale: The Tarasoff duty (duty to warn/protect) requires the PMHNP to breach confidentiality when there is a
serious, credible threat of harm toward an identifiable victim. The presence of delusional content (poisoning
belief), homicidal ideation toward a specific coworker, and the patient's diagnosis of a psychotic disorder together
constitute a serious and foreseeable risk. The clinician must take reasonable steps to protect the victim, including
notifying law enforcement and warning the identified individual. Option A and D represent a breach of the duty to
warn. Option C delays protective action and is clinically inappropriate given the seriousness of the threat.
Documentation of the rationale and actions taken is also required.
Q4: A PMHNP is initiating care with a 45-year-old patient who is being evaluated for major depressive
disorder. The patient states, "I don't want to talk to anyone about my medications — just tell me what
to take." Which response best demonstrates the principle of informed consent in PMHNP practice?
A. "I'll decide the best medication for you based on my expertise and start it today."
B. "You have the right to understand the benefits, risks, alternatives, and consequences of refusing
treatment before we proceed." [CORRECT]
C. "If you refuse treatment, I'll need to document that you are non-adherent and discontinue care."
D. "You don't need to know all the details; just trust that I am the expert here."
Correct Answer: B
Rationale: Informed consent requires that the patient receive clear information about the diagnosis, proposed
treatment, expected benefits, potential risks and adverse effects, reasonable alternatives, and the consequences
of refusing treatment — all in language the patient can understand. The PMHNP must also assess the patient's
decisional capacity. Option A reflects paternalism and violates autonomy. Option C is coercive and constitutes
abandonment risk. Option D reflects a violation of professional standards and informed consent doctrine. Even
when patients defer decisions to the clinician, the consent process must still be completed and documented.
Page 4
